What is Moderna Tokenized Stock (Ondo Tokenized) (MRNAon)?

Quick Facts

• Issuer: Ondo Finance (via Ondo Securities)
• Underlying asset: Moderna, Inc. (MRNA) publicly traded stock
• Backing ratio: 1:1 with real shares held in regulated custody
• Eligible investors: Non-U.S. residents only
• Blockchains: Ethereum, BNB Smart Chain, Solana
• DeFi compatible: Freely transferable and usable in DeFi protocols
• Governance: Proxy voting available via Broadridge ProxyVote

Introduction

MRNAon is a tokenized stock issued by Ondo Finance that gives eligible investors on-chain exposure to Moderna, Inc. — the U.S.-based biotechnology company known for its mRNA platform.

By holding MRNAon, investors gain price exposure to Moderna shares without needing a traditional brokerage account. The token trades around the clock on supported platforms and can move freely across wallets and DeFi protocols.

History & Background

Ondo Finance was founded in 2021 by former Goldman Sachs professionals with a mission to bring institutional-grade financial products onto public blockchains. After building a strong foundation in tokenized U.S. Treasuries, Ondo expanded into tokenized equities and ETFs through its platform, originally called Ondo Global Markets and later rebranded as Ondo Stocks.

MRNAon is part of this expanding catalogue, which has grown to include hundreds of U.S. stocks and ETFs available as on-chain tokens for international investors.

How Moderna Tokenized Stock (Ondo Tokenized) Works

When a user mints MRNAon, Ondo Securities purchases the equivalent number of actual Moderna shares through an institutional brokerage partner. A corresponding token is then issued on-chain — each MRNAon represents one unit of the underlying share held in regulated custody.

Redemption works in reverse: returning MRNAon triggers the sale of the underlying shares and the return of proceeds to the investor. The tokens are designed with built-in compliance controls, meaning on-chain transfers can be monitored, and wallets that violate eligibility rules may be restricted.

LayerZero-powered interoperability allows MRNAon to move between Ethereum, BNB Smart Chain, and Solana seamlessly.

Tokenomics

MRNAon does not follow a fixed issuance schedule. Its supply is elastic — new tokens are minted when investors buy in and burned when investors redeem. This keeps the circulating supply directly tied to real, custodied Moderna shares at all times.

The token does not generate yield on its own; its value tracks the price of the underlying MRNA stock. Fractional ownership is supported, lowering the entry barrier for investors who cannot afford a full share.

Ecosystem & Use Cases

• Equity exposure on-chain: Gain price exposure to Moderna without a traditional broker.
• DeFi integration: MRNAon is freely transferable and can be used within DeFi protocols as collateral or for liquidity.
• 24/7 trading: Unlike traditional markets, tokenized shares can be transferred at any time.
• Proxy voting: Through Broadridge's ProxyVote system, MRNAon holders can submit governance preferences that Ondo applies when voting the underlying shares.

Team, Governance & Community

Ondo Finance operates under a compliance-first model, using offshore special purpose vehicles (SPVs) and regulated broker-dealers to ensure the product stays within international securities law.

The broader Ondo protocol uses the ONDO governance token for protocol-level decisions, while MRNAon itself is a financial product managed by Ondo Securities. Institutional partners such as Broadridge, BitGo, Ledger, and Chainlink support the platform's infrastructure.

Advantages

• Real asset backing: Each token is backed 1:1 by actual Moderna shares in regulated custody.
• Cross-chain availability: Accessible on Ethereum, BNB Smart Chain, and Solana.
• DeFi composability: Freely transferable and compatible with DeFi protocols.
• Fractional access: Buy less than one full share, lowering the investment threshold.
• Proxy voting: Holders can participate in corporate governance via Broadridge.

Risks & Challenges

• Geographic restrictions: Not available to U.S. investors, limiting the addressable market.
• Custodial risk: The underlying shares are held by third-party broker-dealers, introducing counterparty risk.
• Regulatory uncertainty: The tokenized equity space remains subject to evolving global securities regulation.
• Stock-specific risk: MRNAon's value is directly tied to Moderna's performance, which can be highly volatile for a biotech company.
• Compliance controls: Addresses found to violate eligibility requirements can be restricted on-chain.

Long-Term Vision

MRNAon is part of Ondo Finance's broader ambition to make traditional financial markets accessible to anyone on a blockchain. Ondo has set its sights on tokenizing thousands of global securities, aiming to create a permissionless, round-the-clock alternative to conventional brokerage infrastructure.

As the RWA tokenization sector matures, products like MRNAon represent a bridge between DeFi's composability and TradFi's depth — potentially reshaping how global investors access equity markets.